$BDRL
BLONDER TONGUE LABORATORIES INC Stock $bdrl

$bdrl Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000114420417042698 Filed on August 14, 2017

Income Statement

Concept	2017 Q2	2016 Q4	2016 Q2
Revenue	$6.160M	$5.450M	$5.682M
YoY Change	8.41%	4.61%	7.55%
Cost Of Revenue	$4.040M	$3.680M	$3.205M
YoY Change	26.05%	-22.53%	-14.46%
Gross Profit	$2.130M	$1.770M	$2.477M
YoY Change	-14.01%	276.6%	61.26%
Gross Profit Margin	34.58%	32.48%	43.59%
Selling, General & Admin	$1.620M	$1.420M	$1.548M
YoY Change	4.65%	-18.86%	-14.0%
% of Gross Profit	76.06%	80.23%	62.49%
Research & Development	$644.0K	$640.0K	$694.0K
YoY Change	-7.2%	-12.33%	-24.97%
% of Gross Profit	30.23%	36.16%	28.02%
Depreciation & Amortization	$170.0K	$220.0K	$260.0K
YoY Change	-34.62%	-29.03%	-13.33%
% of Gross Profit	7.98%	12.43%	10.5%
Operating Expenses	$2.263M	$2.060M	$2.242M
YoY Change	0.94%	-16.94%	-17.69%
Operating Profit	-$138.0K	-$290.0K	$235.0K
YoY Change	-158.72%	-85.57%	-119.78%
Interest Expense	$93.00K	-$20.00K	-$90.00K
YoY Change	-203.33%	-75.0%	-221.62%
% of Operating Profit			-38.3%
Other Income/Expense, Net
YoY Change
Pretax Income	-$231.0K	-$310.0K	$73.00K
YoY Change	-416.44%	-85.17%	-105.78%
Income Tax	$0.00	$30.00K	$0.00
% Of Pretax Income			0.0%
Net Earnings	-$231.0K	-$340.0K	$73.00K
YoY Change	-416.44%	-84.11%	-105.78%
Net Earnings / Revenue	-3.75%	-6.24%	1.28%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.03	-$0.04	$0.01
COMMON SHARES
Basic Shares Outstanding	8.122M shares	8.098M shares	7.029M shares
Diluted Shares Outstanding			7.036M shares

Balance Sheet

Concept	2017 Q2	2016 Q4	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$360.0K	$470.0K	$310.0K
YoY Change	16.13%	4600.0%	933.33%
Cash & Equivalents	$361.0K	$468.0K	$307.0K
Short-Term Investments
Other Short-Term Assets	$260.0K	$280.0K	$310.0K
YoY Change	-16.13%	0.0%	-13.89%
Inventory	$5.305M	$5.064M	$5.480M
Prepaid Expenses
Receivables	$2.344M	$2.273M	$2.450M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$8.274M	$8.080M	$8.540M
YoY Change	-3.11%	-2.8%	-23.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.160M	$3.279M	$3.390M
YoY Change	-6.78%	-9.44%	-11.95%
Goodwill	$493.0K	$493.0K
YoY Change		0.0%
Intangibles		$117.0K
YoY Change		-74.45%
Long-Term Investments
YoY Change
Other Assets	$380.0K	$428.0K	$1.180M
YoY Change	-67.8%	265.81%	-47.32%
Total Long-Term Assets	$6.440M	$6.920M	$7.021M
YoY Change	-8.28%	-12.59%	-23.96%
TOTAL ASSETS
Total Short-Term Assets	$8.274M	$8.080M	$8.540M
Total Long-Term Assets	$6.440M	$6.920M	$7.021M
Total Assets	$14.71M	$15.00M	$15.56M
YoY Change	-5.44%	-7.58%	-23.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.240M	$1.390M	$870.0K
YoY Change	42.53%	0.22%	-48.82%
Accrued Expenses	$720.0K	$600.0K	$760.0K
YoY Change	-5.26%	-37.5%	-6.17%
Deferred Revenue
YoY Change
Short-Term Debt	$1.970M	$2.120M	$2.230M
YoY Change	-11.66%	-20.3%	-21.75%
Long-Term Debt Due	$246.0K	$228.0K	$3.490M
YoY Change	-92.95%	-93.67%	-6.68%
Total Short-Term Liabilities	$4.176M	$4.616M	$7.610M
YoY Change	-45.12%	-46.46%	-16.56%
LONG-TERM LIABILITIES
Long-Term Debt	$3.211M	$3.335M	$350.0K
YoY Change	817.43%	33250.0%	3400.0%
Other Long-Term Liabilities		$0.00	$0.00
YoY Change
Total Long-Term Liabilities	$3.211M	$3.335M	$350.0K
YoY Change	817.43%	33250.0%	3400.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.176M	$4.616M	$7.610M
Total Long-Term Liabilities	$3.211M	$3.335M	$350.0K
Total Liabilities	$8.113M	$8.466M	$8.080M
YoY Change	0.41%	-1.92%	-12.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$17.67M	-$17.18M
YoY Change		40.83%
Common Stock	$26.69M	$26.14M
YoY Change		-0.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.149M	$1.149M
YoY Change		-79.61%
Treasury Stock Shares	342.0 shares	342.0 shares	1.071K shares
Shareholders Equity	$6.601M	$6.534M	$7.480M
YoY Change
Total Liabilities & Shareholders Equity	$14.71M	$15.00M	$15.56M
YoY Change	-5.44%	-7.58%	-23.69%

Cashflow Statement

Concept	2017 Q2	2016 Q4	2016 Q2
OPERATING ACTIVITIES
Net Income	-$231.0K	-$340.0K	$73.00K
YoY Change	-416.44%	-84.11%	-105.78%
Depreciation, Depletion And Amortization	$170.0K	$220.0K	$260.0K
YoY Change	-34.62%	-29.03%	-13.33%
Cash From Operating Activities	-$20.00K	$10.00K	$490.0K
YoY Change	-104.08%	-102.27%	-173.13%
INVESTING ACTIVITIES
Capital Expenditures	$30.00K	-$30.00K	$0.00
YoY Change			-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$30.00K	$30.00K	$0.00
YoY Change			-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-130.0K	210.0K	-690.0K
YoY Change	-81.16%	31.25%	-163.89%
NET CHANGE
Cash From Operating Activities	-20.00K	10.00K	490.0K
Cash From Investing Activities	-30.00K	30.00K	0.000
Cash From Financing Activities	-130.0K	210.0K	-690.0K
Net Change In Cash	-180.0K	250.0K	-200.0K
YoY Change	-10.0%	-189.29%	150.0%
FREE CASH FLOW
Cash From Operating Activities	-$20.00K	$10.00K	$490.0K
Capital Expenditures	$30.00K	-$30.00K	$0.00
Free Cash Flow	-$50.00K	$40.00K	$490.0K
YoY Change	-110.2%	-109.09%	-142.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3335000	USD
CY2017Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	139000	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1240000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4616000	USD
CY2017Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3211000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	8274000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	275000	USD
CY2017Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	264000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	5064000	USD
CY2017Q2	us-gaap	Inventory Net InventoryNet	5305000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2273000	USD
CY2017Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2344000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	468000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	361000	USD
CY2017Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	398000	USD
CY2017Q2	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	101000	USD
CY2017Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	219000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	197000	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4176000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	139000	USD
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2017Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	26686000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	26132000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17666000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17179000	USD
CY2017Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
CY2016Q2	us-gaap	Selling Expense SellingExpense	664000	USD
CY2016Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-72000	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	988000	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	884000	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	644000	USD
CY2016Q4	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	376000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	6601000	USD
CY2017Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	857000	USD
CY2016Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	991000	USD
CY2017Q2	us-gaap	Liabilities Liabilities	8113000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	8466000	USD
CY2017Q2	us-gaap	Interest Expense InterestExpense	93000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-215000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-487000	USD
	us-gaap	Depreciation Depreciation	163000	USD
CY2017Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	USD
CY2016Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	260000	USD
CY2017Q2	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	587000	USD
	us-gaap	Depreciation Depreciation	233000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	204000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	286000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	152000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	77000	USD
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1278000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1278000	USD
CY2017Q2	us-gaap	Treasury Stock Value TreasuryStockValue	1149000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	-23000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	117000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1527000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1612000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	-76000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	71000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	84000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	493000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	493000	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	380000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	428000	USD
CY2017Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1972000	USD
CY2016Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2120000	USD
CY2017Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	246000	USD
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	228000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-577000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-11000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-159000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-107000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	298000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	694000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-138000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	235000	USD
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.01
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	307000	USD
	us-gaap	Interest Paid InterestPaid	137000	USD
	us-gaap	Interest Paid InterestPaid	152000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	9000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	25000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-142000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	30000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-48000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-50000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-714000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	216000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	470000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	44000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-69000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-13000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	106000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	123000	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-148000	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-436000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-254000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-72000	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	400000	USD
	us-gaap	Interest Expense Other InterestExpenseOther	211000	USD
	us-gaap	Interest Expense Other InterestExpenseOther	21000	USD
CY2017Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	3751000	USD
CY2016Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4001000	USD
CY2017Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	1740000	USD
CY2016Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1860000	USD
CY2017Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3430000	USD
CY2016Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4143000	USD
CY2017Q2	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	2759000	USD
CY2016Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	3949000	USD
	bdr	Percentage Of Fifo Inventory Non Current For Finished Goods PercentageOfFifoInventoryNonCurrentForFinishedGoods	0.6	pure
CY2017Q2	us-gaap	Assets Assets	14714000	USD
CY2016Q4	us-gaap	Assets Assets	15000000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14714000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15000000	USD
CY2017Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	180	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	180	USD
CY2017Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8465	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8465	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8122	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8122	shares
CY2017Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	342	shares
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	342	shares
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	2242000	USD
	us-gaap	Operating Expenses OperatingExpenses	4498000	USD
	us-gaap	Operating Expenses OperatingExpenses	4650000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	12137000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	11625000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	7611000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	6940000	USD
	us-gaap	Gross Profit GrossProfit	4526000	USD
	us-gaap	Gross Profit GrossProfit	4685000	USD
	us-gaap	Selling Expense SellingExpense	1310000	USD
	us-gaap	Selling Expense SellingExpense	1316000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1916000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1947000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1272000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1387000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	28000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	35000	USD
	us-gaap	Interest Expense InterestExpense	373000	USD
	us-gaap	Interest Expense InterestExpense	178000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; LINE-HEIGHT: 115%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.3pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.5in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="48"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <i><font style="FONT-SIZE: 10pt">(a)</font></i></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><i><font style="FONT-SIZE: 10pt">Use of Estimates</font></i></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s significant estimates include stock compensation and reserves related to accounts receivable, inventory and deferred tax assets. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"></div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; LINE-HEIGHT: 115%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.3pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.5in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="48"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <i><font style="FONT-SIZE: 10pt">(b)</font></i></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><i><font style="FONT-SIZE: 10pt">Derivative Financial Instruments</font></i></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><i><font style="FONT-SIZE: 10pt">  </font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company evaluates its convertible instruments to determine if those contracts or embedded components of those contracts qualify as derivative financial instruments to be separately accounted for in accordance with Topic 815 of the Financial Accounting Standards Board (“<b>FASB</b>”) Accounting Standards Codification (<b>“ASC</b>”). The accounting treatment of derivative financial instruments requires that the Company record the embedded conversion option at its fair value as of the inception date of the agreement and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded as non-operating, non-cash income or expense for each reporting period at each balance sheet date. The Company reassesses the classification of its derivative instruments at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Black-Scholes Model (which approximates the Binomial Lattice Model) was used to estimate the fair value of the conversion options that is classified as a derivative liability on the condensed consolidated balance sheets (See Note 6). The model includes subjective input assumptions that can materially affect the fair value estimates. The expected volatility is estimated based on the most recent historical period of time equal to the weighted average life of the conversion options.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Conversion options are recorded as a discount to the host instrument and are amortized as interest expense over the life of the underlying instrument.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q2	us-gaap	Inventory Gross InventoryGross	8921000	USD
CY2016Q4	us-gaap	Inventory Gross InventoryGross	10004000	USD
CY2017Q2	bdr	Inventory Value Before Reserves InventoryValueBeforeReserves	3616000	USD
CY2016Q4	bdr	Inventory Value Before Reserves InventoryValueBeforeReserves	4940000	USD
CY2016	bdr	Percentage Of Fifo Inventory Non Current For Finished Goods PercentageOfFifoInventoryNonCurrentForFinishedGoods	0.68	pure
	us-gaap	Inventory Related Text InventoryRelatedText	Inventories are stated at the lower of cost, determined by the first-in, first-out (“FIFO”) method, or net realizable value.
CY2017Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	402000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	211000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	21000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-231000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	73000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-231000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	73000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-487000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-215000	USD
	bdr	Paid In Kind Director Fee PaidInKindDirectorFee	0	USD
	bdr	Paid In Kind Director Fee PaidInKindDirectorFee	249000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	2263000	USD

Files In Submission

Name	View Source	Status
0001144204-17-042698-index-headers.html	Edgar Link	pending
0001144204-17-042698-index.html	Edgar Link	pending
0001144204-17-042698.txt	Edgar Link	pending
0001144204-17-042698-xbrl.zip	Edgar Link	pending
bdr-20170630.xml	Edgar Link	completed
bdr-20170630.xsd	Edgar Link	pending
bdr-20170630_cal.xml	Edgar Link	unprocessable
bdr-20170630_def.xml	Edgar Link	unprocessable
bdr-20170630_lab.xml	Edgar Link	unprocessable
bdr-20170630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v472130_10q.htm	Edgar Link	pending
v472130_ex31-1.htm	Edgar Link	pending
v472130_ex31-2.htm	Edgar Link	pending
v472130_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BDRL
BLONDER TONGUE LABORATORIES INC Stock $bdrl

2017 Q2 Form 10-Q Financial Statement

#000114420417042698 Filed on August 14, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BDRL BLONDER TONGUE LABORATORIES INC Stock $bdrl

2017 Q2 Form 10-Q Financial Statement

#000114420417042698 Filed on August 14, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BDRL
BLONDER TONGUE LABORATORIES INC Stock $bdrl